EPA + DHA Associated with 25% Lower Risk of Depressive Symptoms in US Adults

Substantial evidence links low blood concentrations of long-chain PUFAs (LC-PUFAs), especially n-3 LC-PUFAs, to the risk of depressive illness, yet the data are inconsistent. For example, serum n-3 LC-PUFAs were not associated with severe depression in middle-aged Finnish men, but were significantly lower in patients with recurrent depressive illness. Others have reported significantly lower concentrations

Read more...

Supplemental EPA or DHA May Be Linked to Improved Depression Scores in Older Adults

Depressive symptoms and cognitive impairment may go hand in hand. If so, treatments for both conditions may be necessary for improving the quality of life and daily functioning of these individuals. A study conducted in the U.S. among cognitively normal 75-year-old adults reported that greater depressive symptoms and cognitive impairments were associated with more cognitive

Read more...